Kumaraguru Raja

Kumaraguru Raja, Ph.D., MBA, is a highly experienced biotechnology analyst currently serving as a Senior Biotechnology Analyst at Brookline Capital Markets since February 2024, and as a Venture Partner at LemVega Capital™. Raja has a robust background in equity research, having held senior positions at firms such as ROTH Capital Partners and NOBLE Capital Markets, where expertise in biotechnology research was a focus. Prior research experiences include postdoctoral roles at The Lundquist Institute for Biomedical Innovation and Mayo Clinic, emphasizing molecular biology and epigenetics. Raja holds an MBA in Finance from the University of California, San Diego, and a Ph.D. in Molecular Microbiology from the University of California, Berkeley.